Condition: Prostate Cancer · Diagnosis · Sponsor: Albany Medical College
The MRI-targeted biopsy for prostate cancer detection can be performed using one of two techniques: 1. Software-based fusion of MRI and ultrasound images (software fusion) or 2. Visually estimated MRI-informed (cognitive fusion) technique To date, there is a lack of adequately powered RCTs directly comparing the cognitive vs fusion targeted biopsy. This randomized study will directly compare the detection rates of clinically significant prostate cancer following either the cognitive or the fusion targeted prostate biopsy in men with suspicious lesions noted on multi-parametric MRI (mp-MRI) of prostate.
This description comes directly from the study's public registry record.
Badar M Mian, MD · 5182623296 · mianb@amc.edu
Always discuss trial participation with your own doctor first.
| Lahey Clinic, Inc | Burlington, Massachusetts, United States | Recruiting |
| Albany Medical Center | Albany, New York, United States | Recruiting |
| Pennsylvania State University | Hershey, Pennsylvania, United States | Not Yet Recruiting |
| Manitoba Prostate Centre, CancerCare Manitoba | Winnipeg, Manitoba, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06517901